Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza.
<h4>Unlabelled</h4>The recent swine H1N1 influenza outbreak demonstrated that egg-based vaccine manufacturing has an Achille's heel: its inability to provide a large number of doses quickly. Using a novel manufacturing platform based on transient expression of influenza surface glyc...
Guardado en:
Autores principales: | Nathalie Landry, Brian J Ward, Sonia Trépanier, Emanuele Montomoli, Michèle Dargis, Giulia Lapini, Louis-P Vézina |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca8e93613f84474b8fe3ee1da465d892 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness of the Pigeon Pox Vaccine on the Chicken Vaccinated With Avian Influenza Vaccine
por: Christine A. Mikhael, et al.
Publicado: (2019) -
Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.
por: Stefan J Halbherr, et al.
Publicado: (2013) -
Evolution of an Eurasian avian-like influenza virus in naïve and vaccinated pigs.
por: Pablo R Murcia, et al.
Publicado: (2012) -
CAvant® WO-60 as an Effective Immunological Adjuvant for Avian Influenza and Newcastle Disease Vaccine
por: Eun-Seo Lee, et al.
Publicado: (2021) -
An avian embryo patient-derived xenograft model for preclinical studies of human breast cancers
por: Loraine Jarrosson, et al.
Publicado: (2021)